Z-1675-2021 Class II Ongoing

Recalled by Roche Diagnostics Operations, Inc. — Indianapolis, IN

FDA device recall Z-1675-2021 was initiated by Roche Diagnostics Operations, Inc. on Apr 26, 2021 and is designated Class II. Reason for recall: Roche received several complaints regarding increased control recovery and discrepant elevated results for the Iron Gen.2 (IRON2) assay on the cobas c311, 501, and 502 analyzers and on the COBAS… The recall status is ongoing. Affected quantity: 20,468 kits.

Recall details

Product Type
Devices
Report Date
Jun 2, 2021
Initiation Date
Apr 26, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
20,468 kits

Product description

IRON GEN 2: ROCHE COBAS INTEGRA ANALYZER, REAGENT CASSETTES, Catalog#: 03183696122 - Product Usage: In vitro test for the quantitative determination of iron in human serum and plasma on Roche/Hitachi cobas c and cobas Integra systems.

Reason for recall

Roche received several complaints regarding increased control recovery and discrepant elevated results for the Iron Gen.2 (IRON2) assay on the cobas c311, 501, and 502 analyzers and on the COBAS Integra 400 plus analyzer.

Distribution pattern

US Nationwide distribution in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, GU, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY.

Code information

UDI: 04015630918904

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1675-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1675-2021. Report a data issue: hello@regdatalab.com.